Innovation in Ireland → ▾
CEO of Zero Locus
Professor of Innovation at The University of Texas at Austin
Medical College of Wisconsin director of research commercialization
Founder, Gilt Groupe
Co-Founder and CEO, DNAnexus
TetraPhase Pharmaceuticals, spun out of Harvard in 2006 with $25 million to develop synthetic antibiotics, reached an important corporate milestone last week: the company had its first paintball outing. Though still... Read more »
Boston · 12/02/141:30 pm - 5:30 pm
Xconomy offers a number of ways to subscribe for free!
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Raleigh-Durham, Boulder/Denver, Texas, Wisconsin and beyond.
© 2007-2014, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Website development support from Andrew Koyfman with design support from Rob Hunter.